AUSTIN, Texas, March 31, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received $642,450 in funding from the Biomedical Advanced Research and Development Authority (BARDA). These funds will help support development, testing, and submission later this week for an Emergency Use Authorization (EUA) for the ARIES® SARS-CoV-2 Assay. This assay will... Read more
The alcohol content of beverages is tightly regulated, and determination of alcohol content in beverages is important for labeling compliance and quality control. Traditional testing methods for alcohol content are typically based upon measurements of physical properties such as specific gravity (relative density) and refractive index. Standardized methods for determination of alcohol by volume use... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 24, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using... Read more
Phase III VIALE-A study showed Venclexta/Venclyxto plus azacitidine helped people with the most common type of aggressive leukaemia in adults live longer compared to azacitidine alone Data will be shared with global health authorities and presented at an upcoming medical meeting Basel, 23 March 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that... Read more
MENLO PARK, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings.... Read more
Combination regimen offers a new 12-month, fixed-duration, chemotherapy-free treatment option for adult patients with chronic lymphocytic leukaemia Results of the phase III CLL14 study add to the growing body of evidence supporting the potential of Venclyxto-based combinations across multiple lines Data showed that a fixed duration of treatment with Venclyxto plus Gazyvaro reduced the risk... Read more
CHELMSFORD, Mass., March 10, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), announced today new leadership appointments and a realignment of its Life Sciences business organization to enhance capabilities and provide for optimal growth and efficiency. Over the past decade, Brooks has undergone a transformation from a pure semiconductor automation company to a company addressing two... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)– Xylem (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced it will postpone its 2020 investor day, originally scheduled for March 31. The decision was made in the interest of the health and safety of all attendees, and is aligned to Xylem’s... Read more
New Multi-Instrument Calibrator Designed to Improve Accuracy and Save Time for Leak Detection and Repair Compliance Thermo Scientific MIC-6 Multi-Instrument Calibrator Designed to Streamline U.S. EPA LDAR Compliance MINNEAPOLIS, March 9, 2020 /PRNewswire/ — For refineries and petrochemical plants, a new multi-instrument calibrator is designed to save time and improve accuracy of daily calibrations and... Read more
First 1.2 GHz NMR System Delivered to CERM at the University of Florence, Italy BALTIMORE–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference 2020 (ENC), Bruker Corporation (Nasdaq: BRKR) announces the recent delivery of the world’s first Avance™ NEO1.2 GHz NMR system to the CERM at the University of Florence, Italy, and the first installation... Read more